AeroLeads people directory · profile
David Campbell Email & Phone Number
President, CEO and Director (Founder)
at
Janux Therapeutics
1 work email found
@januxrx.com
LinkedIn matched
✓ Verified May 2026
4 data sources
Profile completeness 86%
Current company
Role
President, CEO and Director (Founder)
Location
San Diego, California, United States
Company size
Who is David Campbell? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
David Campbell is listed as President, CEO and Director (Founder) at Janux Therapeutics, a company with 101 employees, based in San Diego, California, United States. AeroLeads shows a work email signal at januxrx.com and a matched LinkedIn profile for David Campbell.
David Campbell previously worked as President, CEO & Director (Founder) at Janux Therapeutics and Entrepreneur in Residence at Avalon Ventures. David Campbell holds Doctor Of Philosophy (Phd), Organic Chemistry from Cornell University.
Company email context
Email format at Janux Therapeutics
This section adds company-level context without repeating David Campbell's masked contact details.
{first_initial}{last}@januxrx.com
89% confidence
AeroLeads found 1 current-domain work email signal for David Campbell. Compare company email patterns before reaching out.
Profile bio
About David Campbell
Experienced Chief Executive Officer with a demonstrated history of working in the biotechnology and pharmaceuticals industry. Successful track record of developing new companies, fund raising, and partnering with pharmaceutical companies. Strong research professional with a Doctor of Philosophy (PhD) focused in Organic Chemistry from Cornell University.
Current workplace
David Campbell's current company
Company context helps verify the profile and gives searchers a useful next step.
Janux Therapeutics
14 roles · 35 years
David Campbell work experience
A career timeline built from the work history available for this profile.
President, Ceo & Director (Founder)
CurrentJanux Therapeutics is an innovative biopharmaceutical company developing next-generation therapeutics based on its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to better treat patients suffering from cancer. Janux’s initial focus is on developing a novel class of T cell engagers (TCEs), and its lead product candidates are.
May 2017 - Present
Entrepreneur In Residence
Avalon Ventures
Responsible for the identification, formation and strategic operations of life science portfolio companies including Iron Horse Therapeutics, Adrenergics, Thyritope and Sitari.
Mar 2013 - Dec 2019
Chief Scientific Officer
Sitari was acquired by GlaxoSmithKline in August 2019, after successfully developing inhibitors of Transglutaminase-2 for the treatment of Celiac Disease.
Nov 2013 - Aug 2019
Chief Scientific Officer
Iron Horse Therapeutics
Developing first-in-class treatments for ALS. Humans with mutations that eliminate or reduce the activity of EphA4 live longer with decreased disease severity. Iron Horse Therapeutics will develop EphA4 antagonists based upon the technology developed in Dr. Maurizio Pellecchia's laboratory at Sanford Burnham Prebys.
Nov 2015 - Jun 2018
President & Chief Executive Officer
Enlibrium
Enlibrium is developing novel drugs based on metformin to treat a range of different cancers by reducing cancer energy consumption and reestablishing energy balance. Given their high growth rate and energy requirements, cancers are particularly sensitive to agents that reduce their energy production. Enlibrium was founded based on technology exclusively.
Nov 2015 - Dec 2017
Founder And Chief Scientific Officer
Adrenergics
Developing novel treatments for idiopathic dilated cardiomyopathy.
May 2015 - Aug 2017
Co-Founder And Chief Scientific Officer
Thyritope
Developing modulators of thyroid stimulating hormone receptor autoantibodies for the treatment of Graves' Disease.
Apr 2014 - Jan 2017
Chief Scientific Officer
Mar 2009 - Feb 2013
Interim Chief Scientific Officer
Nov 2010 - Jan 2013
Vice President R & D
2003 - 2009
~6 yrs
Senior Vice President Research
2001 - 2003
~2 yrs
Director Medicinal Chemistry
1998 - 2001
~3 yrs
Director Drug Discovery
Affymax
1991 - 1998
~7 yrs
2 education records
David Campbell education
Doctor Of Philosophy (Phd), Organic Chemistry
Cornell University
Bachelor'S Degree, Organic Chemistry
Harvey Mudd College
FAQ
Frequently asked questions about David Campbell
Quick answers generated from the profile data available on this page.
What company does David Campbell work for?
David Campbell works for Janux Therapeutics.
What is David Campbell's role at Janux Therapeutics?
David Campbell is listed as President, CEO and Director (Founder) at Janux Therapeutics.
What is David Campbell's email address?
AeroLeads has found 1 work email signal at @januxrx.com for David Campbell at Janux Therapeutics.
Where is David Campbell based?
David Campbell is based in San Diego, California, United States while working with Janux Therapeutics.
What companies has David Campbell worked for?
David Campbell has worked for Janux Therapeutics, Avalon Ventures, Sitari Pharmaceuticals, Iron Horse Therapeutics, and Enlibrium.
How can I contact David Campbell?
You can use AeroLeads to view verified contact signals for David Campbell at Janux Therapeutics, including work email, phone, and LinkedIn data when available.
What schools did David Campbell attend?
David Campbell holds Doctor Of Philosophy (Phd), Organic Chemistry from Cornell University.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial